<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Summary of electrophysiology-based screening of TPC agonists.</title><p>Based on chemical structures, LyNa-VAs were divided into two groups: LyNa-VA1.x and LyNa-VA2.x. EC<sub>50</sub> and the average TPC2 currents (<italic>I</italic><sub><sc>TPC2</sc></sub>) were calculated based on 3&#8211;5 whole-cell or whole-endolysosome recordings (see individual data in <xref ref-type="supplementary-material" rid="table1sdata1">Table 1&#8212;source data 1</xref>) for each LyNa-VA, respectively.</p><p><supplementary-material id="table1sdata1"><label>Table 1&#8212;source data 1.</label><caption><title>Electrophysiology-based screening of TPC agonists.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-51423-table1-data1-v1.xlsx"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th>LyNa-VAs</th><th>Chemical name</th><th>Structure</th><th>EC<sub>50</sub> (&#956;M)*</th><th><italic>I</italic><sub>TPC2</sub>&#160;(pA)**</th></tr></thead><tbody><tr><td>LyNa-VA1.1</td><td>Clomipramine</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf1-v1.tif"/><break/></td><td>43&#160;&#177;&#160;2</td><td>945&#160;&#177;&#160;111</td></tr><tr><td>LyNa-VA1.2</td><td>Desipramine</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf2-v1.tif"/><break/></td><td>87&#160;&#177;&#160;8</td><td>1120&#160;&#177;&#160;94</td></tr><tr><td>LyNa-VA1.3</td><td>Imipramine</td><td><inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf3-v1.tif"/></td><td>112&#160;&#177;&#160;1</td><td>433&#160;&#177;&#160;94</td></tr><tr><td>LyNa-VA1.4</td><td>Amitriptyline</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf4-v1.tif"/><break/></td><td>102&#160;&#177;&#160;3</td><td>876&#160;&#177;&#160;196</td></tr><tr><td>LyNa-VA1.5</td><td>Nortriptyline</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf5-v1.tif"/><break/></td><td>52&#160;&#177;&#160;10</td><td>1916&#160;&#177;&#160;361</td></tr><tr><td/><td>Carbamazepine</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf6-v1.tif"/><break/></td><td>No activation</td><td>No activation</td></tr><tr><td>LyNa-VA2.1</td><td>Chlorpromazine</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf7-v1.tif"/><break/></td><td>60&#160;&#177;&#160;2</td><td>1101&#160;&#177;&#160;508</td></tr><tr><td>LyNa-VA2.2</td><td>Triflupromazine</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf8-v1.tif"/><break/></td><td>63&#160;&#177;&#160;2</td><td>984&#160;&#177;&#160;294</td></tr><tr><td/><td>Phenothiazine</td><td> <inline-graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-51423-inf9-v1.tif"/><break/></td><td>No activation</td><td>No activation</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>Data were obtained from whole-cell recordings at &#8722;140 mV.</p><p><sup>**</sup>Data were obtained from whole endolysosome recordings with 100 &#181;M of LyNa-VAs at &#8722;120 mV.</p></fn></table-wrap-foot></table-wrap>